Yüklüyor......
Anti-CD22/CD20 Bispecific Antibody with Enhanced Trogocytosis for Treatment of Lupus
The humanized anti-CD22 antibody, epratuzumab, has demonstrated therapeutic activity in clinical trials of lymphoma, leukemia and autoimmune diseases, treating currently over 1500 cases of non-Hodgkin lymphoma, acute lymphoblastic leukemias, Waldenström’s macroglobulinemia, Sjögren’s syndrome, and s...
Kaydedildi:
Asıl Yazarlar: | , , |
---|---|
Materyal Türü: | Artigo |
Dil: | Inglês |
Baskı/Yayın Bilgisi: |
Public Library of Science
2014
|
Konular: | |
Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4026529/ https://ncbi.nlm.nih.gov/pubmed/24841238 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0098315 |
Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|